Bank of New York Mellon Corp - ZYNERBA PHARMACEUTICALS INC ownership

ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 78 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.81 and the average weighting 0.0%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of ZYNERBA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$8,577
-45.4%
26,311
-28.0%
0.00%
Q1 2023$15,722
-19.1%
36,562
-0.3%
0.00%
Q4 2022$19,431
-28.0%
36,662
-0.2%
0.00%
Q3 2022$27,000
-35.7%
36,743
+0.3%
0.00%
Q2 2022$42,000
-44.0%
36,643
-0.2%
0.00%
Q1 2022$75,000
-29.2%
36,7130.0%0.00%
Q4 2021$106,000
-32.1%
36,7130.0%0.00%
Q3 2021$156,000
+50.0%
36,713
+86.8%
0.00%
Q2 2021$104,000
+4.0%
19,657
-8.8%
0.00%
Q1 2021$100,000
+29.9%
21,552
-8.1%
0.00%
Q4 2020$77,000
+126.5%
23,454
+130.7%
0.00%
Q3 2020$34,0000.0%10,166
+0.0%
0.00%
Q2 2020$34,000
-86.0%
10,165
-84.0%
0.00%
Q1 2020$243,000
-40.9%
63,455
-6.7%
0.00%
Q4 2019$411,000
-11.4%
68,001
+10.6%
0.00%
Q3 2019$464,000
-41.2%
61,457
+5.4%
0.00%
Q2 2019$789,000
+172.1%
58,298
+75.0%
0.00%
Q1 2018$290,000
-27.1%
33,319
+4.7%
0.00%
Q4 2017$398,000
+32.2%
31,815
-11.8%
0.00%
Q3 2017$301,000
-50.0%
36,066
+1.5%
0.00%
Q2 2017$602,000
+145.7%
35,529
+192.1%
0.00%
Q1 2017$245,000
+36.1%
12,165
+5.5%
0.00%
Q4 2016$180,000
+160.9%
11,530
+13.8%
0.00%
Q2 2016$69,00010,1290.00%
Other shareholders
ZYNERBA PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
ETF MANAGERS GROUP, LLC 2,679,457$20,257,0000.73%
Portolan Capital Management 777,293$5,876,0000.66%
CAMPBELL CAPITAL MANAGEMENT INC 110,451$835,0000.62%
ZEKE CAPITAL ADVISORS, LLC 402,212$3,041,0000.27%
Leap Investments LP 46,084$348,0000.17%
Bernardo Wealth Planning LLC 26,419$199,0000.14%
Claraphi Advisory Network, LLC 14,744$111,0000.07%
Sterling Investment Advisors, Ltd. 11,000$83,0000.04%
A.R.T. Advisors, LLC 81,372$615,0000.03%
Mirae Asset Global Investments Co., Ltd. 544,408$4,116,0000.03%
View complete list of ZYNERBA PHARMACEUTICALS INC shareholders